WO2013174148A1 - Method for improving growth performance and/or bone performance of animal - Google Patents
Method for improving growth performance and/or bone performance of animal Download PDFInfo
- Publication number
- WO2013174148A1 WO2013174148A1 PCT/CN2013/000604 CN2013000604W WO2013174148A1 WO 2013174148 A1 WO2013174148 A1 WO 2013174148A1 CN 2013000604 W CN2013000604 W CN 2013000604W WO 2013174148 A1 WO2013174148 A1 WO 2013174148A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- phytase
- animal
- ftu
- per day
- body weight
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 44
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 27
- 238000000034 method Methods 0.000 title claims abstract description 21
- 108010011619 6-Phytase Proteins 0.000 claims abstract description 60
- 229940085127 phytase Drugs 0.000 claims abstract description 38
- JWUBBDSIWDLEOM-NQZHSCJISA-N 25-hydroxy-3 epi cholecalciferol Chemical compound C1([C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=CC=C1C[C@H](O)CCC1=C JWUBBDSIWDLEOM-NQZHSCJISA-N 0.000 claims abstract description 25
- 229940088594 vitamin Drugs 0.000 claims abstract description 11
- 229930003231 vitamin Natural products 0.000 claims abstract description 11
- 235000013343 vitamin Nutrition 0.000 claims abstract description 11
- 239000011782 vitamin Substances 0.000 claims abstract description 11
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 239000003674 animal food additive Substances 0.000 claims abstract description 5
- 230000037396 body weight Effects 0.000 claims description 23
- 235000021052 average daily weight gain Nutrition 0.000 claims description 12
- 241000282849 Ruminantia Species 0.000 claims description 8
- 235000021318 Calcifediol Nutrition 0.000 claims description 6
- 235000021050 feed intake Nutrition 0.000 claims description 6
- 108010080981 3-phytase Proteins 0.000 claims description 4
- 240000006439 Aspergillus oryzae Species 0.000 claims description 4
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 4
- 241000287828 Gallus gallus Species 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 244000144977 poultry Species 0.000 claims description 4
- 241000272525 Anas platyrhynchos Species 0.000 claims description 2
- 241000283690 Bos taurus Species 0.000 claims description 2
- 241000283707 Capra Species 0.000 claims description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 2
- 241001494479 Pecora Species 0.000 claims description 2
- 239000003651 drinking water Substances 0.000 claims description 2
- 235000020188 drinking water Nutrition 0.000 claims description 2
- JWUBBDSIWDLEOM-UHFFFAOYSA-N 25-Hydroxycholecalciferol Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CCC1=C JWUBBDSIWDLEOM-UHFFFAOYSA-N 0.000 abstract description 7
- JWUBBDSIWDLEOM-DCHLRESJSA-N 25-Hydroxyvitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C/C=C1\C[C@@H](O)CCC1=C JWUBBDSIWDLEOM-DCHLRESJSA-N 0.000 abstract description 7
- 210000000689 upper leg Anatomy 0.000 description 24
- 235000014590 basal diet Nutrition 0.000 description 14
- 229910052500 inorganic mineral Inorganic materials 0.000 description 8
- 239000011707 mineral Substances 0.000 description 8
- 229910052698 phosphorus Inorganic materials 0.000 description 7
- 230000002195 synergetic effect Effects 0.000 description 6
- 241000282898 Sus scrofa Species 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 4
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 4
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229940068041 phytic acid Drugs 0.000 description 3
- 235000002949 phytic acid Nutrition 0.000 description 3
- 239000000467 phytic acid Substances 0.000 description 3
- JWUBBDSIWDLEOM-XHQRYOPUSA-N (3e)-3-[(2e)-2-[1-(6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2\C1=C\C=C1/CC(O)CCC1=C JWUBBDSIWDLEOM-XHQRYOPUSA-N 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000031638 Body Weight Diseases 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000000088 Enchondromatosis Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000282324 Felis Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical group CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 208000026616 Ollier disease Diseases 0.000 description 1
- 208000004286 Osteochondrodysplasias Diseases 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001676646 Peniophora lycii Species 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000019730 animal feed additive Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037118 bone strength Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000002144 chemical decomposition reaction Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03008—3-Phytase (3.1.3.8)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/174—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03026—4-Phytase (3.1.3.26), i.e. 6-phytase
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/306—Foods, ingredients or supplements having a functional effect on health having an effect on bone mass, e.g. osteoporosis prevention
Definitions
- the invention is related to a method for improving growth performance and/or bone performance of an animal.
- the invention is related to a method for improving growth performance and/or bone performance of an animal by administering to the animal 25-Hydroxy Vitamin D 3 and phytase.
- Phytase is a type of enzyme that catalyzes the hydrolysis of phytic acid, which is indigestible for organisms, to phosphorus which is digestible for organisms, including 3- phytase and 6-phytase.
- Phytase has been widely used as animal fee additive, which may increase use efficiency of- phosphorus in plant feed by 60%, and decrease phosphorus excreted from feces by 40%, so it is significantly useful to improve production benefit in livestock, agriculture and reduce pollution of phosphorus from phytic acid, (see US 3,297.548; Nelson T. S. et al, J Nutrition, 101; 1289- 1294, 1971; and Nelson T. S. et at, Poult Sci. 47: 1842- 1848, 1968)
- 25-Hydroxy Vitamin D has also been used widely as an animal feed additive.
- US 2003/0170324 discloses a feed premix comprising 25-Hydroxy Vitamin D3 which may be added to poultry, swine, canine, or feline food
- US 2005/0064018 discloses adding a combination of 25-Hydroxy Vitamin D 3 and vitamin D s to animal feed to improve swine 's bone strength
- US 5,695,794 discloses adding a combination of 25- Hydroxy Vitamin D 3 and vitamin D 3 to poultry feed to ameliorate the effects of tibial dyschondroplasia.
- the inventors of the invention found that a combination of 25-Hydroxy Vitamin D 3 and phytase can improve growth performance and/or bone performance of an animal and provide synergistic effect.
- the invention provides a method for improving growth performance and/or bone performance of an animal, comprising administering to the animal an effective amount of 25-Hydroxy Vitamin D3 and phytase.
- the term "animal” includes al l animals including human.
- the examples of the animals include non-ruminants and ruminants. Ruminants include but are not limited to sheep, goat and cattle; and non-ruminants include but are not limited to horse; rabbit; pig including but not limited to infant pig, piglet, growing-fattening pig, sow and boar; and poultry such as turkey, duck and chicken (including but not limited to broiler chicken, egg-laying chicken) etc.
- the term "growth performance” means average daily weight gain (ADWG), average daily feed intake (ADFi) and/or feed conversion rate (FCR) of the animal.
- ADWG average daily weight gain
- ADFi average daily feed intake
- FCR feed conversion rate
- bone performance means fresh weight, length, radius, breaking strength, and/or bone mineral density (BMD), and/or ash, Ca and/or P contents of the bone of the animal .
- administration of 25-Hydroxy Vitamin and phytase to an animal can provide synergistic effects to improve growth performance and/or bone performance of the animal.
- the term "synergistic effect” means the phenomenon of 1+1>2, i.e., two or more substances mutually provide better effect than the summation of effects produced by each one of the substances, or the phenomenon of "mutually promotive effect", i.e., the effect produced by one substance is reinforced in the presence of the other substances.
- 25-Hydroxy Vitamin 3 ⁇ 4 may come from any source, including commercial routes or direct synthesis.
- 25-Hydroxy Vitamin D ? of the invention is synthesized according to the method described in US 4,310,467 and US
- the phytase may be any type of phosphatase enzyme that catalyzes the hydrolysis of phytic acid (myo-inositol hexakisphosphate) and releases a usable form of inorganic phosphorus.
- the phytase of the invention may be 3-phytase, 6-phytase or a combination thereof.
- the phytase of the invention may come from any source including plant and microbiological source, A preferable plant source for phytase is malt.
- Preferred microbiological sources for phytase are Aspergillus oryzae, Aspergillus niger, Aspergillus jieuum and Peniophora lycii, and the phytase from Aspergillus niger has been commercialized for use in animal feed.
- Phytase has also been isolated from E.coli, B. subtilis. and other thermostable microbes.
- phytase Genes encoding phytase have been cloned from many microorganisms, and phytase can easily be produced and purified in industrial scale. Moreover, phytase can be genetically engineered such that it is more resistant to thermal, light, and/or chemical degradation. Examples of commercial phytase are Natuphos 5000 L, NatuphosTM 5000 G, Ronozyme® Hiphos M/L, etc.
- a preferred phytase of the invention is 6-phytase (E.C, 3.1.3.26), preferably produced by a genetically modified strain Aspergillus oryzae (DSMZ 22-594).
- FTU also-called FYT
- FYT is the amount of phytase that liberates 1 pmole phosphate per minute at pH 5.5 and 37°C.
- 25-Hydroxy Vitamin ⁇ % and phytase for administration depends on the particular conditions of the animal. Usually, based on the body weight of the animal to be administered, 25-Hydroxy Vitamin D3 is administered in an amount of 0,2-20 Mg/kg body- weight per day, preferably 0.5- 15 ⁇ /kg body weight per day, more preferably
- the phytase is administered in an amount of 15- 150 FTU/kg body weight per day, preferably 20- 120 FTU/kg body weight per day, more preferably 30-100 FTU/kg body weight per day, even more preferably 50- 80 FTU/kg body weight per day, and most preferably 60 FTU/kg body weight per day.
- the administration may be carried out once a day, or two or more times within one day to the animal.
- 25-Hydroxy Vitamin D 3 and phytase may be administered simultaneously, or separately and successively, for example, administered in an interval of 10 mins. 20 mins, 30 mins, 40 mins, 50 mins, 1 h, 2 h, 3 h or 4 h.
- the 25-Hydroxy Vitamin D 3 and phytase may be directly administered to the animal as a feed composition, or as components of an animal feed or in drinking water of the animal.
- the invention provides use of a composition comprising 25-Hydroxy Vitamin D3 and phytase as an animal feed or feed additive.
- the animal feed or the animal feed with addition of the feed additive comprises 5-500 ⁇ /kg, more preferably 10-300 .ug'kg, even more preferably 20-200 ⁇ ig/kg, even more preferably 40- 100 pg/kg, and most preferably 50 ug ' kg of 25-Hydroxy Vitamin D 3 ; and 500-4000 FTU/kg, more preferably 800-3000 FTU/kg, even more preferably! 000-2500 FTU/kg, even more preferably 1 200-2000 FTU/kg, and most preferably 1500 FTU/kg of phytase *
- Piglets of an initial body weight of 7+0,5 kg were fed a basal diet ad libitum until 1O ⁇ 0.5 kg.
- the formulation of the basal diet was as follows:
- Premix provide in 1000 g of the basal diet: VA. 6600 IU; VD 3> 2000 IU; VH. 50 IU; VK 3) 2 mg; VB ; , 4.5 mg; VB 2 , 8 mg; VB 6 , 6 mg; VB i 2 . 60 ⁇ ; Niacin, 20 mg; pantothenicacid, 32 mg; Folic acid, 0.8 mg; Biotin, 0.23 mg; Choline, 750 mg; I ' e, 150 mg; Zn, 2340 mg; Cu. 120 mg; Mn, 50 mg; I, 0.6 mg; and Se, 0.3 mg
- the 25-Hydroxy Vitamin D 3 used herein was obtained from DSM Nutritional Products Ltd.( Hy - DR. 1.25% Beadlet, Basel, Switzerland), and the 6-phytase used herein was also obtained from DSM Nutritional Products Ltd.(Ronozyme® Hiphos GT , Basel, Switzerland).
- ADWG Average daily weight gain
- ADFI average daily feed intake
- FCR feed conversion rate
- 25-Hydroxy Vitamin D 3 nor 6-phytase or with any one of 25-Hydroxy Vitamin l>, and 6- phytase the piglets administered with both 25-Hydroxy Vitamin D 3 and 6-phytase had quicker weight increase and lower FCR, so 25-Hydroxy Vitamin P 3 and 6-phytase had synergistic effect in improving growth performance of the piglets.
- Example 2 Piglets of an initial body weight of 10 ⁇ 0.5 kg obtained from Example 1 were fed a basal diet ad libitum until 20 ⁇ 0.5 kg. Groups of 8 piglets each were fed as follows:
- C basal diet + 1500 FTU/kg 6-phytase, and no 25-Hydroxy Vitamin D3 was added;
- D basal diet + 50 .ug/kg 25-Hydroxy Vitamin D 3 + 1500 FTU/kg 6-phytase.
- the formulation of the basal diet was as follows:
- Premix provide in 1000 g of the basal diet: VA, 6600 IU; VD 3 , 2000 IU; VE, 50 IU; VK 3 , 2 mg; VBj, 45 mg; VB 2» 8 mg; VB 6 , 6 mg; VB 12 , 60 mi Niacin, 20 mg; pantothenicacid, 32 mg; Folic acid, 0.8 mg; Biotin, 0.23 mg; Choline, 750 mg; F ' e, 150 mg; Zn, 2340 mg; Cu, 120 mg; Mn, 50 mg: I, 0.6 mg; and Se, 0.3 mg
- the used 25-Hydroxy Vitamin I> was obtained from DSM Nutritional Products Ltd.( Hy
- ADWG Average daily weight gain
- AD Ft average daily feed intake
- FCR feed conversion rate
- Femur fresh weight left femur was drawn out, muscles and hamstrings were stripped off to separate the femur (no injury of periosteum and cartilage cap), and then the femur fresh weight was measured.
- Femur length was measured by Vernier Caliper after the femur fresh weight was measured.
- Femur radius femur radius (cannon circumference of femur) was measured at a middle position after the femur fresh weight was measured.
- Femur breaking strength was measured by Electronic Universal Material Mechanics Testing Machines (South China University of Technology, Guangzhou, China) to show the tibial strength. The span was set as 5 cm and the loading speed was set as 3 min/min. The bone was broken at a middle point. The sensor indicated the biggest force loaded during the breaking term, which was expressed as breaking strength (N).
- Femur bone mineral density was measured by Bone Densitometer SD-200 (Beijing Search Institute of Nuclear Industry, Beijing, China) with a radioactive source of low energy nuclides (241 Am). The bone for measuring (fresh sample) was positioned under the detector, and the driving device was started to synchronously move the radioactive source and detector. The amount of radiation penetrating through the bone was detected and bone mineral content (BMC, g/cm) per unit of length was calculated based on the permeation rate. Femur bone mineral density (BMD, g/cm 2 ) was calculated based on the scan length and the bone mineral content (BMC).
- Femur ash content After wrapped with filter papers, the femur was dipped in anhydrous ethanol for dehydration for 24 h and then extracted by ether for degrease for 24 h. After dried to constant weight at 100-105 °C, the dry weight of the dehydrated and degreased femur was recorded. Later, the femur was crushed, carbonized under low temperature until there was no smoke, transferred to a high temperature furnace for burning at 550 °C for 3 h, taken out into a drier for half an hour, and then weighed. It was put into the high temperature furnace for burning for 3 h, into a drier for cooling for half an hour, and then weighed again until the difference between two adjacent weighings was less than 1%. Finally, the ash content of the dehydrated and degreased femur was calculated by:
- Ash Content (%) [ash content after ashed(g)J / [dry weight of degreased bone before ashed (g)] x 100% Femur ash
- Ca content measured by EDTA direct volumetric method (see China State Standard GB/T 6436-92).
- Femur ash P content measured by P-Mo-V acid colorimetric method (see China State
- the data indicate that, the administration of 25-Hydroxy Vitamin D ; and 6-phytase improved bone performance of the piglets.
- the simultaneous administration of 25-Hydroxy Vitamin D 3 and 6-phytase provided synergistic effects in improving bone mineral density and breaking strength, and increasing Ca and P contents of the bone.
Abstract
The invention provides a method for improving growth performance and/or bone performance of an animal. In particularly, the invention provides a method for improving growth performance and/or bone performance of an animal by administering to the animal 25-Hydroxy Vitamin D3 and phytase. The invention also provides use of a composition comprising 25-Hydroxy Vitamin DA and phytase as an animal feed or feed additive.
Description
METHOD FOR IMPROVING GROWTH PERFORMANCE AND/OR BONE PERFORMANCE OF ANIMAL
Technical Field
The invention is related to a method for improving growth performance and/or bone performance of an animal. In particularly, the invention is related to a method for improving growth performance and/or bone performance of an animal by administering to the animal 25-Hydroxy Vitamin D3 and phytase.
Background of Invention
Phytase is a type of enzyme that catalyzes the hydrolysis of phytic acid, which is indigestible for organisms, to phosphorus which is digestible for organisms, including 3- phytase and 6-phytase. Phytase has been widely used as animal fee additive, which may increase use efficiency of- phosphorus in plant feed by 60%, and decrease phosphorus excreted from feces by 40%, so it is significantly useful to improve production benefit in livestock, agriculture and reduce pollution of phosphorus from phytic acid, (see US 3,297.548; Nelson T. S. et al, J Nutrition, 101; 1289- 1294, 1971; and Nelson T. S. et at, Poult Sci. 47: 1842- 1848, 1968)
25-Hydroxy Vitamin D:> has also been used widely as an animal feed additive. For example, US 2003/0170324 discloses a feed premix comprising 25-Hydroxy Vitamin D3 which may be added to poultry, swine, canine, or feline food; US 2005/0064018 discloses adding a combination of 25-Hydroxy Vitamin D3 and vitamin D s to animal feed to improve swine 's bone strength; and US 5,695,794 discloses adding a combination of 25- Hydroxy Vitamin D3 and vitamin D3 to poultry feed to ameliorate the effects of tibial dyschondroplasia.
Surprisingly, the inventors of the invention found that a combination of 25-Hydroxy Vitamin D3 and phytase can improve growth performance and/or bone performance of an animal and provide synergistic effect.
Content of Invention
Therefore, the invention provides a method for improving growth performance and/or bone performance of an animal, comprising administering to the animal an effective amount of 25-Hydroxy Vitamin D3 and phytase.
In the invention, the term "animal" includes al l animals including human. The examples of the animals include non-ruminants and ruminants. Ruminants include but are not limited to sheep, goat and cattle; and non-ruminants include but are not limited to horse; rabbit; pig including but not limited to infant pig, piglet, growing-fattening pig, sow and boar; and poultry such as turkey, duck and chicken (including but not limited to broiler chicken, egg-laying chicken) etc..
In the invention, the term "growth performance" means average daily weight gain (ADWG), average daily feed intake (ADFi) and/or feed conversion rate (FCR) of the animal.
In the invention, the term "bone performance" means fresh weight, length, radius, breaking strength, and/or bone mineral density (BMD), and/or ash, Ca and/or P contents of the bone of the animal .
According to the method of the invention, administration of 25-Hydroxy Vitamin and phytase to an animal can provide synergistic effects to improve growth performance and/or bone performance of the animal. The term "synergistic effect" means the phenomenon of 1+1>2, i.e., two or more substances mutually provide better effect than the summation of effects produced by each one of the substances, or the phenomenon of "mutually promotive effect", i.e., the effect produced by one substance is reinforced in the presence of the other substances.
In the invention, 25-Hydroxy Vitamin ¾ may come from any source, including commercial routes or direct synthesis. For example, 25-Hydroxy Vitamin D? of the invention is synthesized according to the method described in US 4,310,467 and US
3,565,924.
In the invention, the phytase may be any type of phosphatase enzyme that catalyzes the hydrolysis of phytic acid (myo-inositol hexakisphosphate) and releases a usable form of inorganic phosphorus. The phytase of the invention may be 3-phytase, 6-phytase or a combination thereof.
The phytase of the invention may come from any source including plant and microbiological source, A preferable plant source for phytase is malt. Preferred microbiological sources for phytase are Aspergillus oryzae, Aspergillus niger, Aspergillus jieuum and Peniophora lycii, and the phytase from Aspergillus niger has been commercialized for use in animal feed. Phytase has also been isolated from E.coli, B. subtilis. and other thermostable microbes. Genes encoding phytase have been cloned from many microorganisms, and phytase can easily be produced and purified in industrial scale. Moreover, phytase can be genetically engineered such that it is more resistant to thermal, light, and/or chemical degradation. Examples of commercial phytase are Natuphos 5000 L, Natuphos™ 5000 G, Ronozyme® Hiphos M/L, etc.
A preferred phytase of the invention is 6-phytase (E.C, 3.1.3.26), preferably produced by a genetically modified strain Aspergillus oryzae (DSMZ 22-594).
The activity of phytase is measured in FTU units: 1 FTU (also-called FYT) is the amount of phytase that liberates 1 pmole phosphate per minute at pH 5.5 and 37°C.
The amount of 25-Hydroxy Vitamin Ό% and phytase for administration depends on the particular conditions of the animal. Usually, based on the body weight of the animal to be
administered, 25-Hydroxy Vitamin D3 is administered in an amount of 0,2-20 Mg/kg body- weight per day, preferably 0.5- 15 μβ/kg body weight per day, more preferably
1-10 μgfkg body weight per day, even more preferably 1.5-5 μ§/な| body weight per day, and most preferably 2 μg/kg body weight per day; and the phytase is administered in an amount of 15- 150 FTU/kg body weight per day, preferably 20- 120 FTU/kg body weight per day, more preferably 30-100 FTU/kg body weight per day, even more preferably 50- 80 FTU/kg body weight per day, and most preferably 60 FTU/kg body weight per day.
The administration may be carried out once a day, or two or more times within one day to the animal. In addition, 25-Hydroxy Vitamin D3 and phytase may be administered simultaneously, or separately and successively, for example, administered in an interval of 10 mins. 20 mins, 30 mins, 40 mins, 50 mins, 1 h, 2 h, 3 h or 4 h.
The 25-Hydroxy Vitamin D3 and phytase may be directly administered to the animal as a feed composition, or as components of an animal feed or in drinking water of the animal.
Accordingly, in one embodiment, the invention provides use of a composition comprising 25-Hydroxy Vitamin D3 and phytase as an animal feed or feed additive.
Preferably, the animal feed or the animal feed with addition of the feed additive comprises 5-500 μΐ/kg, more preferably 10-300 .ug'kg, even more preferably 20-200 ^ig/kg, even more preferably 40- 100 pg/kg, and most preferably 50 ug'kg of 25-Hydroxy Vitamin D3; and 500-4000 FTU/kg, more preferably 800-3000 FTU/kg, even more preferably! 000-2500 FTU/kg, even more preferably 1 200-2000 FTU/kg, and most preferably 1500 FTU/kg of phytase *
The invention will be further described with reference to the following non-limiting examples.
Examples
Example 1
Piglets of an initial body weight of 7+0,5 kg were fed a basal diet ad libitum until 1O±0.5 kg. Groups of 8 piglets each were fed as follows:
A: basal diet, neither 25-Hydroxy Vitamin D3 nor 6-phytase was added;
B: basal diet + 50 ^ig/kg 25-Hydroxy Vitamin D¾ and no 6-phytase was added;
C: basal diet + 1500 FTU/kg 6-phytase, and no 25-Hydroxy Vitamin D3 was added;
D: basal diet + 50 μξ/kg 25-Hydroxy Vitamin D3 + 1500 FTU/kg 6-phytase.
* Premix provide in 1000 g of the basal diet: VA. 6600 IU; VD3> 2000 IU; VH. 50 IU; VK3) 2 mg; VB;, 4.5 mg; VB2, 8 mg; VB6 , 6 mg; VBi 2. 60 μ§; Niacin, 20 mg; pantothenicacid, 32 mg; Folic acid, 0.8 mg; Biotin, 0.23 mg; Choline, 750 mg; I'e, 150 mg; Zn, 2340 mg; Cu. 120 mg; Mn, 50 mg; I, 0.6 mg; and Se, 0.3 mg
The 25-Hydroxy Vitamin D3 used herein was obtained from DSM Nutritional Products Ltd.( Hy - DR. 1.25% Beadlet, Basel, Switzerland), and the 6-phytase used herein was also obtained from DSM Nutritional Products Ltd.(Ronozyme® Hiphos GT , Basel, Switzerland).
After the feeding term ended, the piglets were not fed for 12 hours and then weighed. Average daily weight gain (ADWG) during the term was calculated, average daily feed intake (ADFI) was calculated based on the feed weight before the feeding and rest feed weight: after the feeding, and feed conversion rate (FCR) was also calculated based on the average daily weight gain and average daily feed Intake (ADFI ADWG)). The experiment was run 6 times in parallel and averages were obtained as follows.
The data indicate that, compared with the piglets administered with neither
25-Hydroxy Vitamin D3 nor 6-phytase or with any one of 25-Hydroxy Vitamin l>, and 6- phytase, the piglets administered with both 25-Hydroxy Vitamin D3 and 6-phytase had quicker weight increase and lower FCR, so 25-Hydroxy Vitamin P3 and 6-phytase had synergistic effect in improving growth performance of the piglets.
Example 2
Piglets of an initial body weight of 10±0.5 kg obtained from Example 1 were fed a basal diet ad libitum until 20±0.5 kg. Groups of 8 piglets each were fed as follows:
A: basal diet, neither 25-Hydroxy Vitamin D3 nor 6-phytase was added;
B: basal diet + 50 .ug/kg 25-Hydroxy Vitamin D?, and no 6-phytase was added,
C : basal diet + 1500 FTU/kg 6-phytase, and no 25-Hydroxy Vitamin D3 was added; D : basal diet + 50 .ug/kg 25-Hydroxy Vitamin D3 + 1500 FTU/kg 6-phytase.
The formulation of the basal diet was as follows:
* Premix provide in 1000 g of the basal diet: VA, 6600 IU; VD3, 2000 IU; VE, 50 IU; VK3, 2 mg; VBj, 45 mg; VB2» 8 mg; VB6 , 6 mg; VB12, 60 mi Niacin, 20 mg; pantothenicacid, 32 mg; Folic acid, 0.8 mg; Biotin, 0.23 mg; Choline, 750 mg; F'e, 150 mg; Zn, 2340 mg; Cu, 120 mg; Mn, 50 mg: I, 0.6 mg; and Se, 0.3 mg
The used 25-Hydroxy Vitamin I>, was obtained from DSM Nutritional Products Ltd.( Hy
• DR. 1.25% Beadlet. Basel, Switzerland), and the used 6-phytase was also obtained from DSM Nutritional Products Ltd.(Ronozyme R Hiphos GT, Basel, Switzerland).
After the feeding term ended, the piglets were kept in limosis for 12 hours and then weighed. Average daily weight gain (ADWG) during the term was calculated, average daily feed intake (AD Ft) was calculated based on the feed weight before the feeding and rest feed weight after the feeding, and feed conversion rate (FCR) was also calculated based on the average daily weight gain and average daily feed intake (ADFI/ADWG). The experiment was run 6 times in parallel and averages were obtained as follows.
The above experimental data also indicate that the simultaneous administration of 25- Hydroxy Vitamin D:, and 6-phytase improved the weight gain and reduced FCR of the piglets and provided synergistic effects.
Example 3
After the feeding of example 2 ended, fresh weight, length, radius, breaking strength, bone mineral density (BMD), and ash, Ca and P contents of the piglets' femurs were measured as below:
Femur fresh weight: left femur was drawn out, muscles and hamstrings were stripped off to separate the femur (no injury of periosteum and cartilage cap), and then the femur fresh weight was measured.
Femur length: Femur length was measured by Vernier Caliper after the femur fresh weight was measured.
Femur radius: femur radius (cannon circumference of femur) was measured at a middle position after the femur fresh weight was measured.
Femur breaking strength: femur breaking strength was measured by Electronic Universal Material Mechanics Testing Machines (South China University of Technology, Guangzhou, China) to show the tibial strength. The span was set as 5 cm and the loading speed was set as 3 min/min. The bone was broken at a middle point. The sensor indicated the biggest force loaded during the breaking term, which was expressed as breaking strength (N).
Femur bone mineral density: femur bone mineral density was measured by Bone Densitometer SD-200 (Beijing Search Institute of Nuclear Industry, Beijing, China) with a radioactive source of low energy nuclides (241 Am). The bone for measuring (fresh sample) was positioned under the detector, and the driving device was started to synchronously move the radioactive source and detector. The amount of radiation penetrating through the bone was detected and bone mineral content (BMC, g/cm) per unit of length was calculated based on the permeation rate. Femur bone mineral density (BMD, g/cm2) was calculated based on the scan length and the bone mineral content (BMC).
Femur ash content: After wrapped with filter papers, the femur was dipped in anhydrous ethanol for dehydration for 24 h and then extracted by ether for degrease for 24 h. After dried to constant weight at 100-105 °C, the dry weight of the dehydrated and degreased femur was recorded. Later, the femur was crushed, carbonized under low temperature until there was no smoke, transferred to a high temperature furnace for burning at 550 °C for 3 h, taken out into a drier for half an hour, and then weighed. It was put into the high temperature furnace for burning for 3 h, into a drier for cooling for half an hour, and then weighed again until the difference between two adjacent weighings was less than 1%. Finally, the ash content of the dehydrated and degreased femur was calculated by:
Ash Content (%) = [ash content after ashed(g)J / [dry weight of degreased bone before ashed (g)] x 100%
Femur ash Ca content: measured by EDTA direct volumetric method (see China State Standard GB/T 6436-92).
Femur ash P content: measured by P-Mo-V acid colorimetric method (see China State
Standard GB/T6437-92).
Each group was measured twice and averages were obtained as follows:
The data indicate that, the administration of 25-Hydroxy Vitamin D ; and 6-phytase improved bone performance of the piglets. Special ly, the simultaneous administration of 25-Hydroxy Vitamin D3 and 6-phytase provided synergistic effects in improving bone mineral density and breaking strength, and increasing Ca and P contents of the bone.
The above examples illustrate the invention without limitation. It should be understood that any person skilled in the art may make obvious amendments and modification to the invention, which should be covered within the protection scope of the present invention.
Claims
Claims
1. A method for improving growth performance and/or bone performance of an animal, comprising administering to the animal an effective amount of 25-Hydroxy Vitamin D:, and phytase.
2. The method of claim 1, wherein the animal is selected from the group consisting of non-ruminants and ruminants, ruminants include but not limited to sheep, goat and cattle, and non-ruminants include but not limited to horse; rabbit; pig including but not limited to infant pig, piglet, growing-fattening pig, sow and boar; and poultry such as turkey, duck and chicken.
3. The method of claim 1, wherein the growth performance is average daily weight gain (ADWG), average daily feed intake (ADFI) and/or feed conversion rate (FCR) of the animal.
4. The method of claim 1, wherein the phytase is 3-phytase, 6 -phytase or a combination thereof.
5. The method of claim 4, wherein the 6-phytase is derived from a genetically modified strain Aspergillus oryzae (DSMZ 22594).
6. The method of any one of claims 1 to 5, wherein, based on the body weight of the animal to be administered, the 25-Hydroxy Vitamin Dj is administered in the amount of 0.2-20 tig/kg body weight per day, preferably 0.5- 15 μ§Λ§ body w eight per day, more preferably 1-10 pg/kg body weight per day, even more preferably 1.5-5 iig/kg body weight per day, and most preferably 2 pgfag body weight per day; and the phytase is administered in an amount of 15- 150 FTU/kg body weight per day, preferabl y 20-120 FTU/kg body weight per day, more preferably 30-100 FTU/kg body weight per day. even more preferably 50-80 FTU/kg body weight per day. and most preferably 60 FTU/kg body weight per day.
7. The method of any one of claims 1 to 5, wherein the 25-Hydroxy Vitamin I>, and the phytase are administered to the animal simultaneously.
8. The method of any one of claims 1 to 5. wherein the 25-Hydroxy Vitamin
the phytase are administered to the animal separately and successively.
9. The method of claim 8, wherein the 25-Hydroxy Vitamin D-, and the phytase are administered to the animal separately in an interval of 10 mins, 20 mins, 30 mins. 40 mins, 50 mins, 1 h, 2 h, 3 h or 4 h.
10. The method of any one of claims 1 to 9, wherein the 25-Hydroxy Vitamin D3 and the phytase are administered to the animal as a feed composition, or as components of an animal feed or in drinking water of the animal.
feed or feed additive.
12. The use of claim 1 1 , wherein the phytase is 3-phytase, ό-phytase or a combination thereof.
13. The method of claim 12, wherein the 6-phytase is derived from a genetically modified strain Aspergillus oryzae (DSMZ 22594).
14. The use of any one of claims 11 to 13, wherein the animal feed or the animal feed with addition of the feed additive comprises 5-500 Hg/kg, preferably 10-300 fig/kg, more preferably 20-200 pg/kg, even more preferably 40-100 Hg/kg, and most preferably 50 μgίkg of 25-Hydroxy Vitamin D3; and 500-4000 FTU/kg, preferably 800-3000 FTU/kg, more preferablyTOOO-2500 FTU/kg, even more preferably 1200-2000 FfU/kg, and most preferably 1500 FTU/kg of phytase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2013265950A AU2013265950A1 (en) | 2012-05-25 | 2013-05-23 | Method for improving growth performance and/or bone performance of animal |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210167106.1 | 2012-05-25 | ||
CN201210167106 | 2012-05-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2013174148A1 true WO2013174148A1 (en) | 2013-11-28 |
Family
ID=49623067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2013/000604 WO2013174148A1 (en) | 2012-05-25 | 2013-05-23 | Method for improving growth performance and/or bone performance of animal |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2013265950A1 (en) |
WO (1) | WO2013174148A1 (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014102643A1 (en) * | 2012-12-27 | 2014-07-03 | Dsm Ip Assets B.V. | Novel use of canthaxanthin and 25-hydroxy vitamin d3 |
WO2015091208A1 (en) * | 2013-12-19 | 2015-06-25 | Dsm Ip Assets B.V. | Use of 25-hydroxy vitamin d3 to promote calcium absorption in ruminants |
CN106719353A (en) * | 2016-11-28 | 2017-05-31 | 平坝县鸿黔养殖场 | A kind of efficient method for breeding of black goat |
CN107821778A (en) * | 2017-10-19 | 2018-03-23 | 界首市双马养殖专业合作社 | A kind of meat sheep fattening period special feed |
WO2020191426A1 (en) * | 2019-03-22 | 2020-10-01 | Jake Stockfeed Pty Ltd | Horse supplement |
CN111955610A (en) * | 2020-08-05 | 2020-11-20 | 中国农业大学 | Application of 25-hydroxy vitamin D3 in improving pig skeleton quality |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993019759A1 (en) * | 1992-03-31 | 1993-10-14 | University Of Georgia Research Foundation, Inc. | Vitamin d derivative feed compositions and methods of use |
-
2013
- 2013-05-23 WO PCT/CN2013/000604 patent/WO2013174148A1/en active Application Filing
- 2013-05-23 AU AU2013265950A patent/AU2013265950A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993019759A1 (en) * | 1992-03-31 | 1993-10-14 | University Of Georgia Research Foundation, Inc. | Vitamin d derivative feed compositions and methods of use |
Non-Patent Citations (1)
Title |
---|
TIAN, PENG FEI: "The Studies of 25-Dihydroxyvitamin D3 And Phytase On Brailer'S Effect And Mechanism", CHINESE MASTER'S THESES FULL-TEXT DATABASE, AGRICULTURE SCIENCE AND TECHNOLOGY, 30 June 2011 (2011-06-30) * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014102643A1 (en) * | 2012-12-27 | 2014-07-03 | Dsm Ip Assets B.V. | Novel use of canthaxanthin and 25-hydroxy vitamin d3 |
WO2015091208A1 (en) * | 2013-12-19 | 2015-06-25 | Dsm Ip Assets B.V. | Use of 25-hydroxy vitamin d3 to promote calcium absorption in ruminants |
CN106719353A (en) * | 2016-11-28 | 2017-05-31 | 平坝县鸿黔养殖场 | A kind of efficient method for breeding of black goat |
CN107821778A (en) * | 2017-10-19 | 2018-03-23 | 界首市双马养殖专业合作社 | A kind of meat sheep fattening period special feed |
WO2020191426A1 (en) * | 2019-03-22 | 2020-10-01 | Jake Stockfeed Pty Ltd | Horse supplement |
CN111955610A (en) * | 2020-08-05 | 2020-11-20 | 中国农业大学 | Application of 25-hydroxy vitamin D3 in improving pig skeleton quality |
Also Published As
Publication number | Publication date |
---|---|
AU2013265950A1 (en) | 2014-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013174148A1 (en) | Method for improving growth performance and/or bone performance of animal | |
Haisan et al. | The effects of feeding 3-nitrooxypropanol on methane emissions and productivity of Holstein cows in mid lactation | |
Dozier III et al. | Apparent metabolizable energy of glycerin for broiler chickens | |
Eiras et al. | Glycerine levels in the diets of crossbred bulls finished in feedlot: apparent digestibility, feed intake and animal performance | |
O'Shea et al. | The effect of protease and xylanase enzymes on growth performance, nutrient digestibility, and manure odour in grower–finisher pigs | |
Hook et al. | Methanogens: methane producers of the rumen and mitigation strategies | |
M'Sadeq et al. | Influence of trace mineral sources on broiler performance, lymphoid organ weights, apparent digestibility, and bone mineralization | |
EP1478376B1 (en) | Immunostimulatory agent comprising a biomass of methanotrophic bacterium | |
Prasai et al. | Effect of biochar, zeolite and bentonite feed supplements on egg yield and excreta attributes | |
Hanczakowska et al. | Short-and medium-chain fatty acids as a feed supplement for weaning and nursery pigs. | |
Skoufos et al. | Effects of oregano essential oil and attapulgite on growth performance, intestinal microbiota and morphometry in broilers | |
Oviedo-Rondón et al. | Ileal and caecal microbial populations in broilers given specific essential oil blends and probiotics in two consecutive grow-outs | |
Wang et al. | Effects of Bacillus subtilis and zinc on the growth performance, internal organ development, and intestinal morphology of male broilers with or without subclinical coccidia challenge | |
Bradbury et al. | Effects of phytase, calcium source, calcium concentration and particle size on broiler performance, nutrient digestibility and skeletal integrity | |
Sahin et al. | Dietary supplementation of probiotic and prebiotic combination (Combiotics) on performance, carcass quality and blood parameters in growing quails | |
Yalçın et al. | Sepiolite as a feed supplement for broilers | |
Aalaei et al. | Effect of single-and multi-strain probiotics on broiler breeder performance, immunity and intestinal toll-like receptors expression | |
Lee et al. | Effects of corn dried distiller's grains with solubles and enzyme premix supplements on growth performance, carcass characteristics and meat quality parameters in finishing pigs | |
YEŞİLBAĞ et al. | Effects of dietary boric acid supplementation on performance, eggshell quality and some serum parameters in aged laying hens | |
Hunde et al. | Supplementation of poultry feeds with dietary zinc and other minerals and compounds to mitigate nitrogen emissions—a review | |
Zhang et al. | Effects of folic acid and sodium selenite on growth performance, nutrient digestion, ruminal fermentation and urinary excretion of purine derivatives in Holstein dairy calves | |
Bao et al. | Effects of dietary manganese supplementation on nutrient digestibility and production performance in male sika deer (Cervus Nippon) | |
Zhao et al. | Effects of phytase and 25‐hydroxyvitamin D3 supplementation on growth performance and bone development in weaned piglets in Ca‐and P‐deficient dietary | |
He et al. | Dietary live yeast supplementation alleviates transport‐stress‐impaired meat quality of broilers through maintaining muscle energy metabolism and antioxidant status | |
Chen et al. | Effect of dietary L‐malic acid supplementation on growth, feed utilization and digestive function of juvenile GIFT tilapia Oreochromis niloticus (Linnaeus, 1758) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13794358 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2013794358 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2013265950 Country of ref document: AU Date of ref document: 20130523 Kind code of ref document: A |